Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension

gan Anna Hemnes, Alexander M.K. Rothman, Andrew J. Swift, Lawrence S. Zisman
Cyhoeddwyd 2020-11-01

Mitral regurgitation quantified by CMR 4D-flow is associated with microvascular obstruction post reperfused ST-segment elevation myocardial infarction

gan Hosamadin Assadi, Ciaran Grafton-Clarke, Ahmet Demirkiran, Rob J. van der Geest, Robin Nijveldt, Marcus Flather, Andrew J. Swift, Vass S. Vassiliou, Peter P. Swoboda, Amardeep Dastidar, John P. Greenwood, Sven Plein, Pankaj Garg
Cyhoeddwyd 2022-05-01

The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry

gan Catherine G. Billings, Robert Lewis, Judith A. Hurdman, Robin Condliffe, Charlie A. Elliot, A.A. Roger Thompson, Ian A. Smith, Matthew Austin, Iain J. Armstrong, Neil Hamilton, Athanasios Charalampopoulos, Ian Sabroe, Andrew J. Swift, Alexander M. Rothman, Jim M. Wild, Allan Lawrie, Judith C. Waterhouse, David G. Kiely
Cyhoeddwyd 2019-05-01

Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)

gan David G. Kiely, David L. Levin, Paul M. Hassoun, Dunbar Ivy, Pei-Ni Jone, Jumaa Bwika, Steven M. Kawut, Jim Lordan, Angela Lungu, Jeremy A. Mazurek, Shahin Moledina, Horst Olschewski, Andrew J. Peacock, G.D. Puri, Farbod N. Rahaghi, Michal Schafer, Mark Schiebler, Nicholas Screaton, Merryn Tawhai, Edwin J.R. van Beek, Anton Vonk-Noordegraaf, Rebecca Vandepool, Stephen J. Wort, Lan Zhao, Jim M. Wild, Jens Vogel-Claussen, Andrew J. Swift
Cyhoeddwyd 2019-09-01